EditorialHuman Studies
Dosage and Response in Radiopharmaceutical Therapy of Painful Osseous Metastases
Edward B. Silberstein
Journal of Nuclear Medicine February 1996, 37 (2) 249-252;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Dosage and Response in Radiopharmaceutical Therapy of Painful Osseous Metastases
Edward B. Silberstein
Journal of Nuclear Medicine Feb 1996, 37 (2) 249-252;
Jump to section
Related Articles
- No related articles found.
Cited By...
- First Clinical Experience with {alpha}-Emitting Radium-223 in the Treatment of Skeletal Metastases
- Radiopharmaceutical Therapy for Palliation of Bone Pain from Osseous Metastases
- Targeting of Osseous Sites with {alpha}-Emitting 223Ra: Comparison with the {beta}-Emitter 89Sr in Mice
- Significant Antitumor Effect from Bone-seeking, {alpha}-Particle-emitting 223Ra Demonstrated in an Experimental Skeletal Metastases Model
- Biologic Dosimetry of Bone Marrow: Induction of Micronuclei in Reticulocytes After Exposure to 32P and 90Y
- Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate